Identifying the survival subtypes of glioblastoma by quantitative volumetric analysis of MRI

Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution

(2013) Sandra H E Boots-Sprenger et al.   MODERN PATHOLOGY

Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age

(2013) Daniela Lötsch et al.   NEURO-ONCOLOGY

Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images

(2013) Kourosh M. Naeini et al.   NEURO-ONCOLOGY

Volumetric and MGMT parameters in glioblastoma patients: Survival analysis

(2012) Georgios Iliadis et al.   BMC CANCER

A Novel Volume-Age-KPS (VAK) Glioblastoma Classification Identifies a Prognostic Cognate microRNA-Gene Signature

(2012) Pascal O. Zinn et al.   PLoS One

A critical evaluation of cystic features in primary glioblastoma as a prognostic factor for survival

(2011) Gurvinder Kaur et al.   JOURNAL OF NEUROSURGERY

Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab

(2011) B. M. Ellingson et al.   NEURO-ONCOLOGY

Scale to Predict Survival After Surgery for Recurrent Glioblastoma Multiforme

(2010) John K. Park et al.   JOURNAL OF CLINICAL ONCOLOGY

Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI

(2009) B. Hakyemez et al.   CLINICAL RADIOLOGY

A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme

(2009) Kaisorn Chaichana et al.   JOURNAL OF NEUROSURGERY

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology

(2009) Richard Simon   Personalized Medicine

The Importance of Tumor Volume in the Prognosis of Patients with Glioblastoma

(2009) Georgios Iliadis et al.   STRAHLENTHERAPIE UND ONKOLOGIE